The average one-year price target for Inspire Medical Systems (NYSE:INSP) has been revised to $95.55 / share. This is a decrease of 27.11% from the prior estimate of $131.09 dated February 1, 2026.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $60.60 to a high of $189.00 / share. The average price target represents an increase of 65.51% from the latest reported closing price of $57.73 / share.
What is the Fund Sentiment?
There are 617 funds or institutions reporting positions in Inspire Medical Systems. This is an decrease of 139 owner(s) or 18.39% in the last quarter. Average portfolio weight of all funds dedicated to INSP is 0.16%, an increase of 26.23%. Total shares owned by institutions increased in the last three months by 3.12% to 41,380K shares. 
The put/call ratio of INSP is 1.38, indicating a bearish outlook.
What are Other Shareholders Doing?
Wellington Management Group Llp holds 2,211K shares representing 7.73% ownership of the company. In its prior filing, the firm reported owning 0K shares , representing an increase of 100.00%.
IJR - iShares Core S&P Small-Cap ETF holds 1,757K shares representing 6.14% ownership of the company. In its prior filing, the firm reported owning 1,834K shares , representing a decrease of 4.38%. The firm decreased its portfolio allocation in INSP by 22.61% over the last quarter.
Deerfield Management Company, L.p. holds 1,506K shares representing 5.27% ownership of the company. In its prior filing, the firm reported owning 1,048K shares , representing an increase of 30.43%. The firm increased its portfolio allocation in INSP by 49.47% over the last quarter.
D. E. Shaw holds 1,212K shares representing 4.24% ownership of the company. In its prior filing, the firm reported owning 359K shares , representing an increase of 70.40%. The firm increased its portfolio allocation in INSP by 297.15% over the last quarter.
William Blair Investment Management holds 1,161K shares representing 4.06% ownership of the company. In its prior filing, the firm reported owning 1,298K shares , representing a decrease of 11.74%. The firm increased its portfolio allocation in INSP by 20.00% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
